The hospital blood bank plays a key role in the diagnosis of acute transfusion reactions involving red cell incompatibility. This paper discusses the interpretation of the serological tests performed by the laboratory. Because red cell incompatible transfusion reactions occur so infrequently it is difficult to accumulate practical experience in their laboratory presentation and this paper describes several of the pitfalls that may be encountered when laboratory findings deviate from classical descriptions. These include the absence of a positive direct antiglobulin test (Coombs) or an incompatible crossmatch, the absence of any apparent discrepancy between the pre-and posttransfusion specimens in cases of ABO incompatibility, the differentiation of auto-immune haemolytic anaemia from delayed transfusion reactions and the assessment of the clinical significance of any blood group antibodies that may be detected.
INTRODUCTION
Transfusion reactions involving red cell incompatibility have always constituted a hazard associated with blood transfusion. If blood were to be transfused at random without regard to the differences in blood groups between donors and recipients then the incidence of incompatible reactions would be in the order of 35070.' In fact, this high incidence was a major contributing factor in discouraging the practice of transfusion therapy until early this century when the discovery of the ABO blood group system by Landsteiner led the way to the application of basic compatibility testing to be applied to the selection of suitable donors. Since that discovery numerous additional tests have been developed, each of which has added a further measure of safety with the result that technical errors are now rarely responsible for reactions involving red cell incompatibility. Nevertheless, although the safety of blood transfusion has improved remarkably since the early attempts, incompatible transfusion reactions continue to occur either because of human error or because certain causes, such as immune delayed transfusion reactions, are unavoidable.
The serological investigation of transfusion reactions must be systematic with much attention being given to economy of effort. There are numerous specimens to be tested and interactions to be considered and without a prepared format a laboratory may easily be submerged under a myriad of tests. The reaction may involve a straightforward incompatibility between the recipient and one or more donor units or alternatively a more complex sequence involving donor-donor incompatibility, or passive incompatible antibody transfer may be experienced. Whatever the cause it is vital to progress quickly as the decision to continue with the transfusion or alternatively to commence vigorous treatment will depend largely upon the laboratory findings.
In order to restrict the range and complexity of the procedures it is important to exclude the more common causes early in the investigation before proceeding to the more unusual. Two tests that should be performed immediately a transfusion reaction is suspected are the direct antiglobulin test on a post-transfusion specimen and rechecking the ABO grouping of the pre-and post-transfusion specimens and of the donor units.
THE DIRECT ANTIGLOBULIN TEST The direct antiglobulin reaction is both a test of recognition that a transfusion reaction has occurred and a test for aetiology. Although transfusion reactions involving red cell incompatibility are commonly accompanied by a positive antiglobulin reaction it is not axiomatic that this will always be the case. A positive reaction can only occur if incompatible red cells are still present in the circulation and this will depend upon the severity of the reaction. In fact there is an inverse relationship between the severity of haemolysis and the strength of the antiglobulin test as the more rapidly the cells are cleared the less chance there is of a positive test. 2 A further complication is that within the ABO system cells may be heavily coated with IgG antibody but fail to give a positive direct antiglobulin test. 3 However, the incompatible antibody may be readily eluted from the cells and an eluate should be prepared regardless of the result of the antiglobulin test and this eluate tested against AI, A2 and B cells. The eluate should also be crossmatched against the donor units as it may represent the only source of incompatible antibody in cases where total absorption of serum antibody has occurred.
ABO BLOOD GROUPING ABO discrepancies remain the most common immunological cause of acute transfusion reactions. Mollison in 1978, in the Bradshaw lecture, I cites two surveys that indicate an incidence of ABO incompatible reactions in the order of 1 in 5000 transfusions. Other surveys cited by Webster 4 in this symposium indicate a slightly lower incidence of 1 in 14,000 within Australia although there are obvious difficulties in assessing the true incidence and this probably accounts for discrepancies between the surveys. Table 1 sets out the serological findings that might be expected following the transfusion of several hundred millilitres of Group A blood to a Group 0 recipient. The relevant features are the mixed field reactions in the cell grouping caused by the presence of surviving incompatible Group A cells and the total absorption of the patient's saline reactive anti-A isoagglutinins. This represents a potentially dangerous situation as the patient may at this stage be easily misgrouped as Group A and further incompatible group A blood transfused. Additionally the crossmatch could &lso be compatible due to the absence of any anti-A in the patient's serum.
ABO incompatible reactions may be even more obscure as is illustrated in Table 2 where an apparent Group A recipient has received twenty-two units of Group A blood and the patient has experienced a massive transfusion reaction as is indicated by the grossly haemolysed post-transfusion specimen. Although the pre-and post-transfusion ABO groups agree by normal grouping methods and no mixed field due to the virtual exchange transfusion, there is, however, a discrepancy when the serum or reverse groups are performed using an indirect antiglobulin technique. The presence of IgG anti-A in the post-transfusion specimen indicates that the recipient is in fact group 0 and that the pretransfusion specimen collected was not from the correct patient. IgG antibodies within the ABO system are particularly useful in the investigation of transfusion reactions as they are not readily absorbed by incompatible blood cells as are the IgM antibodies.
These cases illustrate the value of mixed field reactions and the use of the indirect antiglobulin technique in reverse grouping, both of which are extremely useful tests in the resolution of ABO discrepancies.
DELA YED TRANSFUSION REACTIONS
A delayed transfusion reaction may be defined as any reaction involving blood group antibodies occurring in the absence of demonstrable antibody in the pre-transfusion specimen. There are two exceptions to this definition. Delayed transfusion reactions must Repeating the antibody screening and crossmatch using both pre-and posttransfusion specimens is mandatory. There are a number of causes that will result in the finding of an incompatible antibody only in the post-transfusion specimen in the case of an acute transfusion reaction. 1. The pre-transfusion specimen was not collected from the recipient. 2. Antibody was present in the pretransfusion specimen but at a level below the threshold level of detection. The stimulus of the incompatible transfusion initiated a rapid antibody response. 3. Passive acquisition of antibody from donor plasma. The incompatible antibody may be detected in the recipient's post-transfusion serum or alternatively it may have been totally absorbed onto the incompatible cells. In this case tests on the serum will be negative and detection and identification tests will have to be performed on eluates prepared from the post-transfusion specimen. It ·should also be borne in mind that antibodies within the Kell system have been reported as the cause of severe transfusion reactions involving donor-donor incompatibility.s The reaction occurs following the transfusion of a unit of whole blood containing a high titre Kell antibody to a Kellnegative recipient followed by the transfusion of a unit of Kell-positive blood. be carefully differentiated from acute transfusion reactions resulting from the apparent absence of incompatible antibody caused by either the wrong sample being tested in cases of patient or specimen misidentification or alternatively unsuitable samples being used such as plasma or aged serum. Secondly, acute reactions have been reported involving no demonstrable antibody at any stage. 6 ,7 Because delayed transfusion reactions involve no demonstrable antibody in the pretransfusion serum they are essentially unavoidable and do not implicate technical or clerical errors as a cause. The classical sequence is an uneventful transfusion followed by a variable delay after which there occurs a period of rapid clearance of the remammg incompatible cells. The delay will vary according to the type of immunologic response involved: 8-10 weeks in a primary response, 6-12 days in a secondary response and hours in the case of a sub-threshold activated antibody.
Laboratory investigation
The laboratory usually becomes involved by the finding of an unexpected fall in haemoglobin or jaundice in a hospitalised patient. Due to the time lapse between onset of erythrocyte destruction and the preceding transfusion the symptoms are often not initially recognised as relating to a transfusion reaction. This becomes apparent when either a direct antiglobulin test is requested and found to be Anaesthesia and Intensive Care. Vol. VIIl, No. 2, May, 1980 positive or further blood is crossmatched to compensate for the anaemia and unexpected incompatible antibodies are detected.
Although it is more common for a delayed transfusion reaction to pass undetected, occasionally they may be misdiagnosed as autoimmune haemolytic anaemia when the patient is seen to present with a positive direct antiglobulin test, anaemia, reticulocytosis, spherocytosis and other symptoms associated with a haemolytic process. As a general rule any "auto-immune haemolytic anaemia" developing during a patient's stay in hospital is highly suspect. To differentiate delayed transfusion reactions and auto-immune haemolytic anaemia it is necessary to determine whether the positive antiglobulin test is due to auto-antibody coating the patient's cells as in genuine auto-immune disease or alternatively due to allo-antibody coating the transfused cells. Transfusion history is, therefore, particularly important and cases of confusion will usually occur when this information is withheld from the blood bank. This is particularly a problem in cases of patients transferred from one hospital to another.
Laboratory tests of differentiation include extended testing of specificity of either the free serum antibody if present (or antibody eluted from the positive cells) and reticulocyte testing. In the latter the patient's reticulocytes may be incubated with either the free serum antibody or the eluate and then stained with vital stain, washed and challenged with antiglobulin reagent. A positive test will indicate that genuine auto-antibody is present and reacting with the patient's reticulocytes. A negative test will indicate that allo-antibodies, reactive with transfused cells but not the patient's own cells, are involved.
INTERPRETATION OF RESULTS
Finding an unexpected antibody during the course of the investigation of a suspected transfusion reaction marks the beginning of the Interpretive Phase. Although occasional "rogue" antibodies cause destruction in excess of their entitlement, in general blood group antibodies conform to certain rules. Also antibodies often occur in pairs or clusters and it is essential that the search for atypical antibodies is not concluded too hastily after finding the first positive result. This is Anaesthesia and Intensive Care, Vol. Vllf, No. 2, May, 1980 particularly important when clinically insignificant antibody distracts the investigator from the presence of a second clinically active antibody. It is, therefore, essential to correlate the serological findings with the nature and degree of symptoms observed. Three criteria for the clinical significance of serological findings are the strength of the antibody, the ability to fix complement and the thermal range.
Antibodies of high titre or avidity will generally cause more severe reactions than weaker antibodies. However, it is particularly important to differentiate between a genuine weak antibody and a strong antibody temporarily weakened either by absorption by incompatible cells or exhaustion of supply. An illustrative comparison is the different reactions that would be anticipated in an acute transfusion reaction and a delayed transfusion reaction involving anti-Jka. In the former because incompatible Jk(a +) cells are introduced into a pool of preformed antibody resulting in the simultaneous destruction of a large number of cells the reaction would be expected to be severe. Antibody would be expected to be in excess and, therefore, demonstrable in the post-transfusion serum. In the case of a delayed transfusion reaction the development of the antibody occurs over a period of time resulting in sequential clearance of cells. Symptoms may be subclinical or only mild and, with antigen in excess, free serum antibody may not be demonstrable immediately.
Antibodies able to fix complement generally give rise to more acute reactions as they can mediate intravascular haemolysis. Classical examples of these antibodies are those in the Kell, Kidd, Duffy and Ss systems. Noncomplement fixing antibodies, such as those within the Rhesus system, mediate immune clearance by the reticuloendothelial system and reactions are usually less acute. However, in cases of extremely potent antibodies, haemoglobinuria may occur when the rate of clearance exceeds the capacity of the reticuloendothelial system to handle the increased haemoglobin load.
Finally, antibodies not active at or near 37 QC are not considered to be clinically significantl. A severe reaction in which only anti-PI was detected at room temperature would almost certainly have a cause other than the anti-PI antibody. The danger is that in inexperienced hands the findings of the anti-PI may act as a "red herring".
One other reaction that may present is the occurrence of a transfusion reaction in the absence of demonstrable antibody6,7. In a survey of the literature including 10 cases of reactions involving no demonstrable antibody, 5 cases involved rapid destruction of transfused cells and the remaining 5 showed shortened survival time but no clinical symptoms. There is obviously little that the laboratory can do in such cases.
CONCLUSIONS
There has been no attempt in this paper to set out detailed methods or schedules of tests as these are very much subject to individual choice. The following sequence (Figure 1 ) is offered as an example of an orderly approach to an investigation of a suspected acute transfusion reaction progressing from determining that a reaction has occurred, through the more common causes and finally
POST-TRANSFV~10K
SPECThlENS involving the laboratory in more involved procedures.
(1) Test for haemoglobinanaemia and haemoglobinuria. Clerical check. With the possible exception of the preparation of eluates none of these tests is difficult to perform or requires complicated equipment and, therefore, may be performed equally well by both large and small centres. Interpretation of results can be more complex and the small hospital, perhaps investigating its first reaction, is obviously at a disadvantage. Nevertheless a great deal of interpretive assistance may be given over the telephone with the result that no patient should need to receive a second-rate investigation. 
